Leading investment bank and brokerage service, Oppenheimer & Co, released their top picks list on November 16.
Oppenheimer's 33 equity analysts picked an individual stock they believe will outperform over the next 12 months, based on fundamentals and market conditions.Visit Business Insider's homepage for more storiesOppenheimer & Co, a leading full-service brokerage and investment bank, released its top equity ideas list on November 16. "These are the most timely stocks in the opinion of our research analysts," the report explained.
Each of Oppenheimer's 33 equity analysts picked an individual stock they believe will outperform over the next 12 months based on fundamentals and market conditions. This week, investors have been returning to value and recovery stocks as the vaccine frontrunners, Pfizer, Moderna and AstraZeneca,. This has led to a rotation out of growth stocks, many of which were stay-at-home winners, into value stocks, which have been worst-hit by the pandemic.
Investors continue to move into risk assets, such as equities, in search of income as bond yields remain low. Many top investment banks have been advising investors toHowever, the continual rise of COVID-19 cases combined with
Predicted by soothsayers? Sorry, I'm not trusting my wealth to a crystal ball.
wow